Navigation Links
More evidence needed for scale up of mobile device technology in health
Date:2/12/2013

Despite the hundreds of pilot studies using mobile healthalso known as 'mHealth'', which describe medical and public health practice supported by mobile devices there is insufficient evidence to inform the widespread implementation and scale-up of this technology, according to international researchers writing in this week's PLOS Medicine.

There are over 6 billion mobile phone subscribers and 75% of the world has access to a mobile phone leading health care providers, researchers, and national governments to be optimistic about the opportunities mobile health has to offer. However, the authors led by Mark Tomlinson from Stellenbosch University in South Africa, question the evidence supporting the scale up of mHealth.

The authors say: "In some ways, mobile technology has a magical appeal for those interested in global public health over and above the advantages that have been proven with good evidence."

They continue: "Part of this magical promise is that mobile technologies may solve one of the most difficult problems facing global health effortsthat of structural barriers to access."

However, according to the authors while enthusiasm for effective mHealth interventions in sub-Saharan Africa is high, little is known about their efficacy or effectiveness.

They say: "The current wave of mHealth interventions are the equivalent of black boxes. Each small entrepreneur or researcher includes whatever bells and whistles that their funding allows in an attempt to demonstrate efficacy."

The authors argue that potential innovative research designs such as multi-factorial strategies, randomized controlled trials, and data farming may provide this evidence base and make several recommendations for the way forward.

The authors also argue that major donors could invest in creating a robust set of standards and a platform that can inform and support local adaptation of mHealth applications. The standard
'/>"/>

Contact: Sumrina Yousufzai
syousufzai@plos.org
415-568-3164
Public Library of Science
Source:Eurekalert

Page: 1 2

Related biology technology :

1. More evidence for longevity pathway
2. New Epidemiological Data Provide Additional Safety Evidence for LantusĀ®
3. endpoint Adopts New Technology To Boast Most Robust IVR Validation Objective Evidence and Decrease IVR Build Timelines
4. First Evidence that Adipose Stem Cell-Based Critical Limb Ischemia Treatment is Safe & Effective is published in Circulation Journal by Lead Investigator Dr. Han Cheol Lee of Pusan National University
5. Caris Life Sciences Adds Next-Generation Sequencing to Enhance Evidence-Based Tumor Profiling Service for Cancer Patients
6. Fundamental steps needed now in global redesign of Earth system governance
7. Larger refuges needed to sustain success of transgenic corn
8. New life sciences R&D model based on real-time learning and data-sharing needed to sustain innovation
9. UMass Amherst, Harvard experts say better systems needed for medical device cybersecurity
10. A firm molecular handshake needed for hearing and balance
11. Sandy Mold Extends Its Health Risks to Hired Cleaners; My Cleaning Products Says Complete Mold Treatment Gear and Molderizer are Needed to Stop Mold and Its Risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 23, 2014 China ... the "Company"), a leading fully integrated plasma-based biopharmaceutical ... announced that its majority-owned subsidiary, Shandong Taibang Biological ... ("GMP") certification from the China Food and Drug ... production facility. As previously disclosed in the Company,s ...
(Date:12/24/2014)... 2014  Rock Creek Pharmaceuticals, Inc., (NASDAQ: ... Clinical Trial Application (CTA) with the United ... seeking regulatory approval to initiate clinical trials for the ... Contingent on the Company receiving CTA regulatory approval, ... to assess the safety, tolerability and dose escalation of ...
(Date:12/22/2014)... 2014 /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB: REPCF) ... on the development of autologous cell therapies, announced today ... of Calgary in conjunction with co-authors from Kyoto University ... the company,s ongoing clinical research using dermal sheath cup ... The paper entitled " Hair Follicle Dermal ...
(Date:12/22/2014)... 2014 The American Journal ... original research, reviews and editorials addressing developments and ... today published a provocative article exploring the role ... and potential treatment of prostate cancer. , ... proposes the possibility that there could be a ...
Breaking Biology Technology:China Biologic Receives GMP Certification for New Coagulation Factor Facility 2China Biologic Receives GMP Certification for New Coagulation Factor Facility 3Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 2Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 4Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 5Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 4
... -- Traffic.com, Inc., has launched interactive, personalized services ... www.traffic.com , the company announced Thursday. Traffic.com will ... immediate, at-a-glance displays of roadway traffic conditions including ... it said in a news release. , ,Data ...
... Telecommunications, Inc., has expanded its business continuance practice ... , ,The new service provides customers with ... basis for critical data. The disk-based system delivers ... unlike tape back-up systems, the company said. , ...
... - The Tascon Group has launched the Tascon Business Analyst ... job costing. , ,The Business Analyst is being offered as ... . , ,The program is based on a business valuation ... - a system known as the optimization method. , ,"It ...
Cached Biology Technology:
(Date:12/19/2014)...   LaunchKey , the first decentralized mobile authentication ... of Things era, today announced the close of $3 ... led by Metamorphic Ventures with participation from ENIAC Ventures, ... others.  LaunchKey has raised $4 million to date, and ... and bring LaunchKey to market in 2015. ...
(Date:12/17/2014)... , Dec. 15, 2014 The ... make it easier to detect and prevent counterfeit ... Today the agency started performing an in-house ... will validate the authenticity of purchased microcircuits while ... new quality control measures will be conducted at ...
(Date:12/17/2014)... N.C. , Dec. 16, 2014 Valencell, ... licensed its PerformTek biometric technology to industry leaders such ... highly accurate, clinically validated, biometric wearable products. These products ... 6-9 in Las Vegas . ... technology is accurate, flexible and robust – with the ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2
... tummy,s taste for red wine with red meat , ... when red wine meets red meat? If the rendezvous happens ... of healthful chemical compounds may thwart formation of harmful substances ... which reinforces the benefits of consuming wine and other foods ...
... at Chicago have identified a novel function for an enzyme ... respiratory distress syndrome, also known as ARDS. The finding ... of lung inflammation and injury. The research will be published ... and online June 29. ARDS is an often fatal ...
... times larger than their wild relatives. How did they ... larger fruits, heads of grain, tubers, etc, because this is ... for food. In addition to size, tomatoes have been ... it has been difficult to study these traits in tomatoes, ...
Cached Biology News:American Chemical Society's Weekly PressPac -- June 25, 2008 2American Chemical Society's Weekly PressPac -- June 25, 2008 3American Chemical Society's Weekly PressPac -- June 25, 2008 4American Chemical Society's Weekly PressPac -- June 25, 2008 5American Chemical Society's Weekly PressPac -- June 25, 2008 6American Chemical Society's Weekly PressPac -- June 25, 2008 7American Chemical Society's Weekly PressPac -- June 25, 2008 8American Chemical Society's Weekly PressPac -- June 25, 2008 9UIC researchers make promising finding in severe lung disease 2Evolution of fruit size in tomato 2Evolution of fruit size in tomato 3
... Activity Kit ADAM17 Activity Kit TNF-α Converting ... PROTECT FROM LIGHT. AVOID FREEZE/THAW CYCLES. The ... and sensitive assay designed to measure human ... samples and for screening enzyme inhibitors. An ...
... unique agarose-digesting enzyme developed by Promega for ... or RNA from agarose gels. The enzyme ... (LMP) agarose melted at 6575C does not ... temperature before hydrolysis. Simply place the tube ...
...
... FREEZE. Nuclear matrix proteins (NMPs) make up the ... associated with such functions as DNA replication, RNA ... matrix has been shown to be highly insoluble ... that cell death releases soluble nuclear matrix proteins ...
Biology Products: